Maxcyte vs Nrc Health: revenue, profit, margins and growth compared
Maxcyte brought in $33M of revenue in fiscal 2025, Nrc Health $137.4M in fiscal 2025. Revenue changed by -14.5% at Maxcyte and -4.0% at Nrc Health on the year before, so Nrc Health grew faster. Maxcyte kept -135.1% of its revenue as net profit, Nrc Health 8.2%. Free cash flow was -$36.2M at Maxcyte and $15.7M at Nrc Health.
Fiscal years as each company reports them; the two may end in different months.
Questions about Maxcyte and Nrc Health
Which is bigger by revenue, Maxcyte or Nrc Health?
Nrc Health is bigger by revenue: $137.4M in fiscal 2025, against $33M for Maxcyte in fiscal 2025.
Which keeps more of its revenue as profit, Maxcyte or Nrc Health?
Maxcyte had a net margin of -135.1% in fiscal 2025; Nrc Health had 8.2% in fiscal 2025.
Which grew revenue faster, Maxcyte or Nrc Health?
In their latest fiscal years revenue changed by -14.5% at Maxcyte and -4.0% at Nrc Health.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.